BioSpace News Archive

FDA

FDA approves first continuous glucose monitoring system with a fully implantable glucose sensor and compatible mobile app for adults with diabetes

The U.S. Food and Drug Administration today approved the Eversense Continuous Glucose Monitoring (CGM) system for use in people 18 years of age and older with diabetes. This is the first FDA-approved CGM system to include a fully implantable sensor to detect glucose, which can be worn for up to 90 days.

June 21, 2018
·
4 min read
Business

Kinetiq and KPIT Announce Strategic Life Sciences Collaboration

KPIT and Kinetiq are partnering to enhance advisory consulting and testing as a service (TaaS) for software solutions engagements involving compliance to various global regulations, including 21 CFR Part 11, Annex 11, HIPAA, and other regulated technology compliance programs in the life sciences field

June 21, 2018
·
2 min read
Biotech Beach

CytRx Corporation Highlights Review of NantCell Inc’s Aldoxorubicin Published in Future Oncology

Clinical studies with aldoxorubicin demonstrated increased progression-free survival and tumor response with low cardiotoxicity

June 21, 2018
·
4 min read
Drug Development

New Acucela Data on the Effect of Emixustat Hydrochloride on Retinal Thickness in Diabetic Retinopathy

Acucela Inc., announced today new data on the effect of emixustat hydrochloride on retinal thickness in diabetic retinopathy (DR).

June 21, 2018
·
7 min read
Business

CellGenix Completed First Step of Facility Expansion to Stay on Top of the Increasing Demands for GMP Cell Culture Reagents

CellGenix, successfully completed the first phase of its headquarters’ expansion.

June 21, 2018
·
2 min read